To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Dallas company working to ...

Colossal Biosciences is pulling one final surprise out of its hat in 2025. Announced today, the company’s nonprofit arm—The Colossal Foundation—secured an additional $50 million in funding, doubling ...

Pastiera is wonderful. I did like my Titan 2 already, but coming from the F(x)tec Pro1 running Linux, the simpler keyboard of the Titan 2 was leaving much to desire. Now with Pastiera, it finally ...

It’s the time of year when best-of lists make their rounds. As usual, we’ve deliberated and selected some of our favorite monographs, surveys, and whimsical tomes published in 2025. Several of these ...

The end of the year is quickly approaching and so is the season of giving. By choosing to shop with us this year, you’re supporting independent publishing and allowing us continue to share important ...

It’s not new news that the much-maligned Cities: Skylines II did not manage to come close to the success of the first game in the series. Colossal Order and Paradox Interactive’s difficult second ...

This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris ...

ViaGen has successfully cloned endangered species like Przewalski’s horses. Elizabeth Arellano Photography/Courtesy Colossal Biosciences However, Colossal CEO Ben Lamm insists the move wasn’t ...

Two Texas-based biotechnology companies are joining forces on a mission to reverse extinction. Colossal Biosciences Inc., the Dallas-based genetics company that claimed to have brought back the dire ...

C.M. Edwards is a writer currently employed by Valnet as a GameRant lists writer. He has been working professionally as a writer and editor for the past seven years in multiple fields, including comic ...